These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 28299800)

  • 21. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
    Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation, characterization, and pharmacokinetics study of capsaicin via hydroxypropyl-beta-cyclodextrin encapsulation.
    Zhao Y; Sun C; Shi F; Firempong CK; Yu J; Xu X; Zhang W
    Pharm Biol; 2016; 54(1):130-8. PubMed ID: 25853954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
    Patel SG; Rajput SJ
    AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of levodropropizine and hydroxypropyl-β-cyclodextrin association on the physicochemical characteristics of levodropropizine loaded in hydroxypropyl-β-cyclodextrin microcontainers: Formulation and in vitro characterization.
    Yousaf AM; Qadeer A; Raza SA; Chohan TA; Shahzad Y; Din FU; Khan IU; Hussain T; Alvi MN; Mahmood T
    Polim Med; 2019; 49(1):35-43. PubMed ID: 31769938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation, Characterization, and Bioavailability of Host-Guest Inclusion Complex of Ginsenoside Re with Gamma-Cyclodextrin.
    Li H; Zhang G; Wang W; Chen C; Jiao L; Wu W
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and Characterization of the Sulfobutylether-β-Cyclodextrin Inclusion Complex of Amiodarone Hydrochloride with Enhanced Oral Bioavailability in Fasted State.
    Wang D; Chen G; Ren L
    AAPS PharmSciTech; 2017 Jul; 18(5):1526-1535. PubMed ID: 27757923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computer-Aided Formulation Design for a Highly Soluble Lutein-Cyclodextrin Multiple-Component Delivery System.
    Zhao Q; Miriyala N; Su Y; Chen W; Gao X; Shao L; Yan R; Li H; Yao X; Cao D; Wang Y; Ouyang D
    Mol Pharm; 2018 Apr; 15(4):1664-1673. PubMed ID: 29505718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin.
    Hu L; Zhang H; Song W; Gu D; Hu Q
    Carbohydr Polym; 2012 Nov; 90(4):1719-24. PubMed ID: 22944438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement on dissolution rate of inclusion complex of Rifabutin drug with β-cyclodextrin.
    Shanmuga Priya A; Sivakamavalli J; Vaseeharan B; Stalin T
    Int J Biol Macromol; 2013 Nov; 62():472-80. PubMed ID: 24076034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation, characterization and in vivo evaluation of a formulation of dantrolene sodium with hydroxypropyl-β-cyclodextrin.
    Chen M; Wu Q; Jiang J; Jin X; Liu S; Wang M; Zhao C
    J Pharm Biomed Anal; 2017 Feb; 135():153-159. PubMed ID: 28027523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Docetaxel/dimethyl-β-cyclodextrin inclusion complexes: preparation,
    Giri BR; Lee J; Lim DY; Kim DW
    Drug Dev Ind Pharm; 2021 Feb; 47(2):319-328. PubMed ID: 33576707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation and characterization of eprosartan mesylate and β-cyclodextrin inclusion complex prepared by microwave technology.
    Ahad A; Bin Jardan YA; Hassan MZ; Raish M; Ahmad A; Al-Mohizea AM; Al-Jenoobi FI
    Drug Deliv; 2022 Dec; 29(1):1512-1522. PubMed ID: 35549506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solubility Enhancement of Myricetin by Inclusion Complexation with Heptakis-
    Han D; Han Z; Liu L; Wang Y; Xin S; Zhang H; Yu Z
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of Cyclodextrin-Based Nanosponges for Solubility and Bioavailability Enhancement of Rilpivirine.
    Rao MRP; Chaudhari J; Trotta F; Caldera F
    AAPS PharmSciTech; 2018 Jul; 19(5):2358-2369. PubMed ID: 29869305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elucidation of the orientation of selected drugs with 2-hydroxylpropyl-β-cyclodextrin using 2D-NMR spectroscopy and molecular modeling.
    Adhikari S; Daftardar S; Fratev F; Rivera M; Sirimulla S; Alexander K; Boddu SHS
    Int J Pharm; 2018 Jul; 545(1-2):357-365. PubMed ID: 29747001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An optimized commercially feasible milling technique for molecular encapsulation of meloxicam in β-cyclodextrin.
    Bandarkar FS; Vavia PR
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1318-28. PubMed ID: 21506882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physicochemical [corrected] properties of the inclusion complex of puerarin and glucosyl-β-cyclodextrin.
    Liu B; Zhao J; Liu Y; Zhu X; Zeng J
    J Agric Food Chem; 2012 Dec; 60(51):12501-7. PubMed ID: 23215052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and in vivo evaluation of an inclusion complex of oridonin and 2-hydroxypropyl-beta-cyclodextrin.
    Yan Z; Xu W; Sun J; Liu X; Zhao Y; Sun Y; Zhang T; He Z
    Drug Dev Ind Pharm; 2008 Jun; 34(6):632-41. PubMed ID: 18568914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complexation of oxethazaine with 2-hydroxypropyl-β-cyclodextrin: increased drug solubility, decreased cytotoxicity and analgesia at inflamed tissues.
    Prado AR; Yokaichiya F; Franco MKKD; Silva CMGD; Oliveira-Nascimento L; Franz-Montan M; Volpato MC; Cabeça LF; de Paula E
    J Pharm Pharmacol; 2017 Jun; 69(6):652-662. PubMed ID: 28211640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.